![](/img/cover-not-exists.png)
A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia
Ghobrial, IM, Roccaro, AM, Matous, J, Padmanabhan, W, Badros, A, Schlossman, R, Chuma, S, Leduc, R, Nelson, M, O'Connor, K, Sam, A, Harris, B, Soumerai, J, Warren, D, Birner, A, Munshi, NC, Treon, SP,Volume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70616-3
Date:
February, 2009
File:
PDF, 112 KB
english, 2009